Image

Clinical Performance of HVGIC vs Bulk Fill Composite in Class II Cavities of Posterior Teeth: A 12-Month RCT

Clinical Performance of HVGIC vs Bulk Fill Composite in Class II Cavities of Posterior Teeth: A 12-Month RCT

Recruiting
18-45 years
All
Phase N/A

Powered by AI

Overview

Study Title:

Clinical Performance of Highly Viscous Glass Ionomer versus Bulk Fill Resin Composite Restorative Materials in Moderate Class II Cavities of Permanent Posterior Teeth: A 12-Month Randomized Clinical Study

Study Design:

Split-mouth, randomized clinical trial on 31 patients with at least two moderate Class II carious lesions in permanent posterior teeth. Each patient receives two restorations-bulk fill resin composite on one side and highly viscous glass ionomer (HVGIC) on the other.

Aim

To compare the clinical performance of bulk fill resin composite and HVGIC restorations over 1 week (baseline), 6 months, and 12 months using the modified United States Public Health Services (USPHS) criteria.

Primary Outcome:

Marginal adaptation of the restorations

Secondary Outcomes:

  1. Anatomic form
  2. Contact point
  3. Restoration retention
  4. Marginal discoloration
  5. Surface texture
  6. Color match
  7. Secondary caries
  8. Postoperative sensitivity

Methodology Highlights:

Evaluation by two blinded examiners

Standardized cavity prep and material application

Clinical evaluation using USPHS criteria at all follow-up intervals

Statistical analysis with chi-square, ANOVA, or non-parametric tests as appropriate (R software v4.3.2)

Ethical Considerations:

Approved by the Faculty of Dentistry, Ain Shams University Research Ethics Committee

Informed consent will be obtained from all participants

Significance

This study helps determine whether HVGIC can be a clinically viable alternative to bulk fill resin composite in moderate Class II cavities, with implications for durability, patient compliance, and cost-effectiveness

Description

Title

Clinical Performance of Highly Viscous Glass Ionomer versus Bulk Fill Resin Composite Restorative Materials in Moderate Class II Cavities of Permanent Posterior Teeth: A 12-Month Randomized Clinical Study

Study Overview:

This study is a prospective, randomized, split-mouth clinical trial designed to compare the clinical performance of bulk fill resin composite and highly viscous glass ionomer (HVGIC) restorative materials in moderate Class II cavities of permanent posterior teeth over a 12-month period. The evaluation of restorations will be based on the modified United States Public Health Services (USPHS) criteria at three time intervals: 1 week (baseline), 6 months, and 12 months post-treatment.

Rationale and Background:

The challenge of achieving a long-lasting, mechanically resilient, esthetically acceptable restoration in stress-bearing areas such as Class II cavities continues to drive innovation in restorative dentistry. While resin composites offer favorable physical and esthetic properties, their inherent polymerization shrinkage and technique sensitivity have prompted the development of alternatives like bulk fill composites, which allow deeper curing and reduced shrinkage. Meanwhile, glass ionomer materials-notably HVGICs-have seen advancements aimed at improving their physical and mechanical properties, particularly with the introduction of resin coating systems such as the EQUIA system. The need for comparative clinical evaluation under real-world conditions remains critical to guide clinical decision-making.

Aim of the Study:

To evaluate and compare the clinical performance of bulk fill resin composite and highly viscous glass ionomer restorations in moderate Class II cavities of permanent posterior teeth over time using the modified USPHS evaluation criteria.

Objectives

To assess the clinical behavior of bulk fill resin composite and HVGIC restorations in Class II cavities.

To determine the effect of time (1 week, 6 months, and 12 months) on the clinical performance of these restorative materials.

Research Question:

Is there a significant difference in the clinical performance between bulk fill resin composite and highly viscous glass ionomer restorations in moderate Class II cavities of permanent teeth over a 12-month follow-up?

Hypothesis

The null hypothesis (H₀) states that there is no significant difference in clinical performance between the two restorative materials, nor does the time interval significantly influence their performance.

Study Design:

A split-mouth, randomized controlled clinical trial involving 31 patients, each presenting with at least two moderate Class II carious lesions, one on each side of the mouth. This design allows direct intra-individual comparison between materials under similar oral conditions.

Setting

Outpatient clinics of the Operative Dentistry Department, Faculty of Dentistry, Ain Shams University, Cairo, Egypt.

Sample Size Calculation:

Based on a power analysis with α = 0.05, β = 0.2 (power = 80%), and an effect size of ω = 0.398, the calculated sample size was 62 restorations (31 patients). A 15% increase was added to account for possible dropouts, resulting in a final sample of 72 restorations (36 patients).

Randomization and Blinding:

Random allocation will be performed using www.randomization.com. Allocation concealment will be ensured, and two independent blinded evaluators will perform outcome assessment at each follow-up point.

Clinical Procedure:

Bulk fill composite group: Rubber dam isolation, selective enamel etching, universal adhesive application, placement of bulk fill composite per manufacturer's instructions.

HVGIC group: Cotton roll isolation, cavity conditioning with polyacrylic acid, insertion of HVGIC using a capsule system, finishing with diamond stones on the same day.

Follow-up and Evaluation:

Clinical evaluation at 1 week, 6 months, and 12 months using the modified USPHS criteria, which include:

Statistical Analysis:

Categorical data: Chi-square test

Numerical and ordinal data: Shapiro-Wilk test for normality

If normally distributed: Repeated measures ANOVA with Bonferroni post hoc test

If not: Friedman's test with Dunn's post hoc

Significance level: p < 0.05

Software: R version 4.3.2 for Windows

Ethical Considerations:

Study approved by the Faculty of Dentistry, Ain Shams University Research Ethics Committee

Participants will provide informed written consent

No harm expected beyond standard dental procedures; restorations needing repair or replacement will be redone free of charge

Funding

No external funding was received.

Risks and Benefits:

Risks

Minimal: possible restoration failure requiring repair or replacement

Benefits

Free treatment and 12-month follow-up

Improved understanding of restorative options for clinicians and patients

Research Significance:

This study provides valuable clinical data comparing two widely used restorative materials under routine conditions. The findings may influence material selection in moderate Class II cavities and support evidence-based improvements in clinical practice.

Eligibility

Inclusion Criteria:

  1. Patients aged 18 to 45 years
  2. Systemically healthy individuals
  3. Patients with at least two Class II carious lesions (one on each side) in permanent posterior teeth
  4. Vital, symptomless teeth
  5. Teeth in occlusion and in contact with adjacent natural teeth
  6. Healthy periodontal tissues
  7. Carious lesions of moderate depth (outer or middle third of dentin radiographically)
  8. Patients likely to return for recall visits

Exclusion Criteria:

  1. Medically compromised patients
  2. Pregnant or breastfeeding women
  3. Poor oral hygiene
  4. Patients undergoing orthodontic treatment
  5. Patients with parafunctional habits (e.g., bruxism)
  6. Extensive lesions requiring cusp coverage
  7. Absence of adjacent or opposing teeth

Study details
    Comparison of Bulk Fill vs HVGIC in Class II Cavities

NCT07067164

Ain Shams University

22 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.